Medtech developments over the Christmas period

The final week of the year was a quiet one for medtech, but a few things still stood out. Encouraging signs on testing for Covid-19 have been seen in the US, with the FDA moving to get more assays – both antigen-based and PCR tests – to market quickly.

And just before Christmas, two company acquisitions were announced, one of them – that of Ortho Clinical Diagnostics by Quidel – in the billions of dollars. This last hurrah has taken the total spent on medtech M&A in 2021 to over $50bn. Important events to have occurred in the medtech sector over the past week or so include the following.